Mitchell Stephen Ray
- SEC CIK
- 0001802653
No open-market purchases or sales filed in the past year.
Current role at each company
- VNDA Vanda Pharmaceuticals Inc.Directoras of Jun 8, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Mitchell Stephen Ray as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 16, 2025 (view filing) | Jun 13 | 3 days | Mitchell Stephen RayDirector | SSale | −7.00K | $4.59 | −$32.1K | −6.7%97.1K after | |
| Nov 18, 2024 (view filing) | Nov 14 | 4 days | Mitchell Stephen RayDirector | SSale | −5.00K | $5.17 | −$25.9K | −10.0%44.9K after | |
| Aug 11, 2023 (view filing) | Aug 10 | 1 day | Mitchell Stephen RayDirector | SSale | −6.50K | $6.05 | −$39.3K | −18.1%29.3K after | |
| Jun 14, 2022 (view filing) | Jun 13 | 1 day | Mitchell Stephen RayDirector | SSale | −2.70K | $9.48 | −$25.6K | −29.3%6.51K after | |
| Sep 13, 2021 (view filing) | Sep 9 | 4 days | Mitchell Stephen RayDirector | SSale | −19.1K | $16.74 | −$319.9K | −67.5%9.21K after |